Julien Caumartin
PhD
Medicine
Immunology and Microbiology
Paris, France
Julien Caumartin is a Chief Scientific Officer at Invectys. Julien ensures the scientific integrity of the company’s research operations. He has 15+ years of R&D experience in immunology, 9 of which he spent leading a research team developing new immunotherapies against cancer. Before working at Invectys, he first worked at the Scripps Research Institute, where his research was focused on anti-tumoral vaccination. He then worked at the French CEA, studying the interaction between the immune system and the replication of prion, before going back to anti-tumor vaccination by joining Intelectys, and finally Invectys. He has worked in both public and private structures and has been involved in 13 publications and 5 patents related to immuno-oncology and currently leads Invectys’ anti-HLA-G CAR-T cell project. Julien earned his Ph.D. in immunology from the Paris Diderot University.